Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > The evidence is clear

<< Previous

Bullboard Posts

Next >>

Comment by CMHarring218431on May 23, 2024 1:34pm

162 Views

Post# 36054296

RE:RE:RE:RE:RE:The evidence is clear

Right on Canada! Oncy is being taken down on low volume. The price sucks but no biggy. This is weak hands folding and everybody needs a little cash now and then. To me and more importantly, it is a classic example of the mm's manipulating it down ahead of anticipated news. they make money on the way down and again on the way back up.
Might be time to at least dream about those personal needs and purchases being realized. IMHO Why not

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland